Ajanta Pharma reports 30% fall in Q3 consolidated net profit

02 Feb 2023 Evaluate

Ajanta Pharma has reported results for third quarter ended December 31, 2022.

The company has reported fall of 36.34% in its net profit at Rs 123.96 crore for Q3FY23 as compared to Rs 194.71 crore for the corresponding quarter previous year. However, total income of the company increased by 8.24% to Rs 905.40 crore for the quarter under review as compared to Rs 836.48 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported fall of 29.86% in its net profit at Rs 134.51 crore for Q3FY23 as compared to Rs 191.78 crore for the same quarter in the previous year. However, total income of the company increased by 16.79% to Rs 1,006.70 crore for the quarter under review as compared to Rs 861.94 crore for the same quarter in the previous year.

Ajanta Pharma Share Price

2137.85 6.45 (0.30%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.